{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:28:08Z","timestamp":1791041288031,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00277-019-03778-9","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T13:03:16Z","timestamp":1566910996000},"page":"2367-2377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Characteristics, combinations, treatments, and survival of second primary hematological neoplasm: a retrospective single-center cohort of 49 patients (Hemo2study)"],"prefix":"10.1007","volume":"98","author":[{"given":"Thomas","family":"Chalopin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Vallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavie","family":"Arbion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Barin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Rault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Villate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Eloit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurianne Drieu","family":"La Rochelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Foucault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Ertault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dartigeas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotfi","family":"Benboubker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Estienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"H\u00e9rault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Gyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,27]]},"reference":[{"issue":"3","key":"3778_CR1","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3324\/haematol.2010.033779","volume":"96","author":"E Rumi","year":"2011","unstructured":"Rumi E, Passamonti F, Elena C, Pietra D, Arcaini L, Astori C, Zibellini S, Boveri E, Pascutto C, Lazzarino M (2011) Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients. Haematologica. 96(3):454\u2013458","journal-title":"Haematologica."},{"issue":"10","key":"3778_CR2","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1038\/s41375-018-0027-y","volume":"32","author":"A-R Landtblom","year":"2018","unstructured":"Landtblom A-R, Bower H, Andersson T et al (2018) Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients. Leukemia. 32(10):2203\u20132210","journal-title":"Leukemia."},{"key":"3778_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000342484","volume":"129","author":"G Hauck","year":"2013","unstructured":"Hauck G, Jonigk D, Kreipe H, Hussein K (2013) Simultaneous and sequential concurrent myeloproliferative and lymphoproliferative neoplasms. Acta Haematol 129:187\u2013196","journal-title":"Acta Haematol"},{"key":"3778_CR4","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.leukres.2015.05.002","volume":"39","author":"L Masarova","year":"2015","unstructured":"Masarova L, Newberry K, Pierce S et al (2015) Association of lymphoid malignancies and Philadelphia-chromosome negative myeloproliferative neoplasms: clinical characteristics, therapy and outcome. Leuk Res 39:822\u2013827","journal-title":"Leuk Res"},{"issue":"5","key":"3778_CR5","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3109\/10428194.2015.1092527","volume":"57","author":"G Todisco","year":"2016","unstructured":"Todisco G, Manshouri T, Verstovsek S, Masarova L, Pierce SA, Keating MJ, Estrov Z (2016) Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics. Leuk Lymphoma 57(5):1054\u20131059","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"3778_CR6","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ajh.22171","volume":"86","author":"L Laurenti","year":"2011","unstructured":"Laurenti L, Tarnani L, Nichele I et al (2011) The coexistence of chronic lymphocytic leukemia and myeloproliferative neoplasms: a retrospective multicentric GIMEMA experience. Am J Hematol 86(12):1007\u20131021","journal-title":"Am J Hematol"},{"issue":"3","key":"3778_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/10428190802713521","volume":"50","author":"F Palandri","year":"2009","unstructured":"Palandri F, Derenzini E, Ottaviani E et al (2009) Association of essential thrombocythemia and non-Hodgkin lymphoma: a single-centre experience. Leuk Lymphoma 50(3):481\u2013484","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"3778_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/1066896911417242","volume":"20","author":"K Oka","year":"2012","unstructured":"Oka K, Nagayama R, Yonekawa N, Nihei T, Sando N, Yatabe Y, Mori N (2012) Concurrent gastric MALT and Hodgkin lymphoma: a case report. Int J Surg Pathol 20(2):201\u2013204","journal-title":"Int J Surg Pathol"},{"issue":"9","key":"3778_CR9","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1080\/10245332.2018.1466428","volume":"23","author":"R Kotchetkov","year":"2018","unstructured":"Kotchetkov R, Ellison E, McLean J, Pressnail B, Nay D (2018) Synchronous dual hematological malignancies: new or underreported entity? Hematology. 23(9):596\u2013599","journal-title":"Hematology."},{"issue":"20","key":"3778_CR10","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","volume":"165","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E, Voulgarelis M, Moutsopoulos HM et al (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165(20):2337\u20132344","journal-title":"Arch Intern Med"},{"issue":"3","key":"3778_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/bjh.13192","volume":"168","author":"G Nocturne","year":"2015","unstructured":"Nocturne G, Mariette X (2015) Sj\u00f6gren syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol 168(3):317\u2013327","journal-title":"Br J Haematol"},{"issue":"25","key":"3778_CR12","doi-asserted-by":"publisher","first-page":"6515","DOI":"10.1182\/blood-2011-04-348755","volume":"118","author":"H Frederiksen","year":"2011","unstructured":"Frederiksen H, Farkas DK, Christiansen CF, Hasselbalch HC, Sorensen HT (2011) Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study. Blood. 118(25):6515\u20136520","journal-title":"Blood."},{"issue":"1","key":"3778_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/10428194.2015.1071492","volume":"57","author":"N Khanal","year":"2016","unstructured":"Khanal N, Giri S, Upadhyay S, Shostrom VK, Pathak R, Bhatt VR (2016) Risk of second primary malignancies and survival of adult patients with polycythemia vera: a United States population-based retrospective study. Leuk Lymphoma 57(1):129\u2013133","journal-title":"Leuk Lymphoma"},{"issue":"16","key":"3778_CR14","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1182\/blood-2011-12-401455","volume":"119","author":"MC Susini","year":"2012","unstructured":"Susini MC, Masala G, Antonioli E, Pieri L, Guglielmelli P, Palli D, Bosi A, Vannucchi AM (2012) Risk of second cancers in chronic myeloproliferative neoplasms. Blood. 119(16):3861\u20133862","journal-title":"Blood."},{"issue":"4","key":"3778_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1586\/17474086.2013.826910","volume":"6","author":"S Salmoiraghi","year":"2013","unstructured":"Salmoiraghi S, Montalvo MLG, D\u2019Agostini E et al (2013) Mutations and chromosomal rearrangements of JAK2: not only a myeloid issue. Expert RevHematol 6(4):429\u2013439","journal-title":"Expert RevHematol"},{"issue":"9","key":"3778_CR16","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/2159-8290.CD-14-0104","volume":"4","author":"F Damm","year":"2014","unstructured":"Damm F, Mylonas E, Cosson A, Yoshida K, Della Valle V, Mouly E, Diop M, Scourzic L, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Kikushige Y, Davi F, Lambert J, Gautheret D, Merle-Beral H, Sutton L, Dessen P, Solary E, Akashi K, Vainchenker W, Mercher T, Droin N, Ogawa S, Nguyen-Khac F, Bernard OA (2014) Acquired initiation mutations in early hematopoietic cells of CLL patients. Cancer Discov 4(9):1088\u20131101","journal-title":"Cancer Discov"},{"issue":"5","key":"3778_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3324\/haematol.2017.177212","volume":"103","author":"A Agathangelidis","year":"2018","unstructured":"Agathangelidis A, Ljungstr\u00f6m V, Scarfo L et al (2018) Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations. Haematologica. 103(5):865\u2013873","journal-title":"Haematologica."},{"issue":"6","key":"3778_CR18","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/ajh.20870","volume":"82","author":"L Henry","year":"2007","unstructured":"Henry L, Carillo S, Jourdan E, Arnaud A, Brun S, Lavabre-Bertrand T (2007) Association of essential thrombocythemia and chronic lymphocytic leukemia: absence of the V617F JAK2 mutation in the lymphoid compartment. Am J Hematol 82(6):500\u2013501","journal-title":"Am J Hematol"},{"issue":"20","key":"3778_CR19","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 127(20):2391\u20132405","journal-title":"Blood."},{"issue":"20","key":"3778_CR20","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision to the World Health Organization classification of lymphoid neoplasms. Blood. 127(20):2375\u20132390","journal-title":"Blood."},{"issue":"2","key":"3778_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.respe.2015.12.017","volume":"64","author":"S Le Guyader-Peyrou","year":"2016","unstructured":"Le Guyader-Peyrou S, Belot A, Maynadi\u00e9 M et al (2016) Cancer incidence in France over the 1980-2012 period: hematological malignancies. Rev Epidemiol Sante Publique 64(2):103\u2013112","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"23","key":"3778_CR22","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","volume":"113","author":"KH Lim","year":"2009","unstructured":"Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, McClure RF, Li CY, Pardanani A (2009) Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 113(23):5727\u20135736","journal-title":"Blood"},{"issue":"6","key":"3778_CR23","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1158\/0008-5472.CAN-16-2234","volume":"77","author":"P Valent","year":"2017","unstructured":"Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O, Sotlar K, Sperr WR, Escribano L, George TI, Kluin-Nelemans HC, Ustun C, Triggiani M, Brockow K, Gotlib J, Orfao A, Schwartz LB, Broesby-Olsen S, Bindslev-Jensen C, Kovanen PT, Galli SJ, Austen KF, Arber DA, Horny HP, Arock M, Metcalfe DD (2017) Advances in the classification and treatment of mastocytosis: current status and outlook toward the future. Cancer Res 77(6):1261\u20131270","journal-title":"Cancer Res"},{"issue":"1","key":"3778_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/ajh.10322","volume":"73","author":"VA Pullarkat","year":"2003","unstructured":"Pullarkat VA, Bueso-Ramos C, Lai R, Kroft S, Wilson CS, Pullarkat ST, Bu X, Thein M, Lee M, Brynes RK (2003) Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinico- pathologic features and activating c-KIT mutations. Am J Hematol 73(1):12\u201317","journal-title":"Am J Hematol"},{"issue":"11","key":"3778_CR25","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/ajh.24553","volume":"91","author":"A Pardanani","year":"2016","unstructured":"Pardanani A (2016) Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management. Am J Hematol 91(11):1146\u20131159","journal-title":"Am J Hematol"},{"issue":"1","key":"3778_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/leu.2015.284","volume":"30","author":"M Jawhar","year":"2016","unstructured":"Jawhar M, Schwaab J, Schnittger S, Meggendorfer M, Pfirrmann M, Sotlar K, Horny HP, Metzgeroth G, Kluger S, Naumann N, Haferlach C, Haferlach T, Valent P, Hofmann WK, Fabarius A, Cross NCP, Reiter A (2016) Additional mutations in SRSF2, ASXL1 and\/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis. Leukemia. 30(1):136\u2013143","journal-title":"Leukemia."},{"issue":"4","key":"3778_CR27","first-page":"308","volume":"35","author":"A Papoudou-Bai","year":"2018","unstructured":"Papoudou-Bai A, Marinos L, Papathanasiou K et al (2018) Simultaneous presence of follicular, diffuse large-B cell lymphoma and Hodgkin-like lymphoma. Turk J Haematol 35(4):308\u2013309","journal-title":"Turk J Haematol"},{"issue":"1","key":"3778_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00277-017-3151-2","volume":"97","author":"T Fischer","year":"2018","unstructured":"Fischer T, Zing NPC, Chiattone CS, Federico M, Luminari S (2018) Transformed follicular lymphoma. Ann Hematol 97(1):17\u201329","journal-title":"Ann Hematol"},{"issue":"16","key":"3778_CR29","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1056\/NEJM199904223401604","volume":"340","author":"A Brauninger","year":"1999","unstructured":"Brauninger A, Hansmann ML, Strickler JG et al (1999) Identification of common germinal-center B-cell precursors in two patients with both Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma. N Engl J Med 340(16):1239\u20131247","journal-title":"N Engl J Med"},{"issue":"12","key":"3778_CR30","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1200\/JCO.1999.17.12.3804","volume":"17","author":"T Marafioti","year":"1999","unstructured":"Marafioti T, Hummel M, Anagnostopoulos I, Foss HD, Huhn D, Stein H (1999) Classical Hodgkin\u2019s disease and follicular lymphoma originating from the same germinal B cell. J Clin Oncol 17(12):3804\u20133809","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03778-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03778-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03778-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T23:11:03Z","timestamp":1598397063000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03778-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["3778"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03778-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"assertion":[{"value":"15 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethical committee in human research of the Hospital of Tours (project Hemo<sup>2<\/sup> Study no. 2018-108).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}